Preclik G, Stange E F, Gerber K, Fetzer G, Horn H, Schneider A, Ditschuneit H
University of Ulm, Department of Internal Medicine II, FRG.
Dig Dis Sci. 1989 Dec;34(12):1860-4. doi: 10.1007/BF01536703.
Using 14C-labeled arachidonic acid as precursor for in vitro prostaglandin synthesis, the effect of an antacid containing Al (OH)3, Mg(OH)2 and CaCO3 on endogenous prostaglandin synthesis was investigated in antral and duodenal mucosa of healthy volunteers. After three weeks of treatment with a high-dose antacid, there was no detectable change in the total capacity of the mucosa for prostaglandin synthesis, but the prostaglandin profile was markedly altered. The relative amounts of PGE2 and PGF2 alpha synthesized by antral and duodenal mucosa increased at the expense of the prostaglandins A2/B2, thromboxane A2, and prostacyclin. In a short-term study, this change was not observed following a single antacid dose within 1 hr after application. It is concluded that long-term antacid treatment may alter the prostaglandin pattern formed by gastroduodenal mucosa and this may be related to its therapeutic effect.
以14C标记的花生四烯酸作为体外前列腺素合成的前体,研究了一种含有氢氧化铝、氢氧化镁和碳酸钙的抗酸剂对健康志愿者胃窦和十二指肠黏膜内源性前列腺素合成的影响。在使用高剂量抗酸剂治疗三周后,黏膜前列腺素合成的总能力没有可检测到的变化,但前列腺素谱明显改变。胃窦和十二指肠黏膜合成的PGE2和PGF2α的相对量增加,而前列腺素A2/B2、血栓素A2和前列环素的合成量减少。在一项短期研究中,在服用抗酸剂后1小时内单次给药未观察到这种变化。结论是长期抗酸剂治疗可能会改变胃十二指肠黏膜形成的前列腺素模式,这可能与其治疗效果有关。